Swarthmore Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-33,550
Closed -$5.61M 34
2020
Q3
$5.61M Hold
33,550
1.77% 27
2020
Q2
$5.45M Buy
33,550
+30,850
+1,143% +$5.53M 1.86% 24
2020
Q1
$467K Sell
2,700
-32,650
-92% -$6.5M 2.47% 21
2019
Q4
$7.09M Sell
35,350
-800
-2% -$164K 1.65% 25
2019
Q3
$7.64M Sell
36,150
-950
-3% -$198K 1.89% 17
2019
Q2
$7.2M Buy
37,100
+33,500
+931% +$6.18M 1.77% 22
2019
Q1
$592K Sell
3,600
-39,250
-92% -$6.94M 2.54% 22
2018
Q4
$8.06M Buy
+42,850
New +$7.91M 2.1% 14
2017
Q1
Sell
-189,675
Closed -$21.9M 46
2016
Q4
$21.9M Sell
189,675
-175
-0.1% -$19.5K 3.27% 7
2016
Q3
$19.8M Buy
+189,850
New +$19.8M 3.8% 10

Other funds holding CME

Swarthmore Group's CME Position: Q4 2020 in Review

Swarthmore Group sold out of CME Group (CME) in Q4 2020, closing a stake of 33,550 shares — an estimated $5.61M sold.

Swarthmore Group first reported a position in CME in Q3 2016 and held it in 10 quarters. The position peaked at $21.9M in Q4 2016. 1,030 funds tracked by Wall St. Rank hold CME as of Q4 2020.

  • Swarthmore Group reported no remaining CME Group position as of Q4 2020 after selling out during the quarter.
  • Swarthmore Group sold 33,550 CME Group shares in Q4 2020, an estimated $5.61M.
  • Swarthmore Group first reported a position in CME Group in Q3 2016 and held it in 10 quarters.
  • Swarthmore Group's CME Group position peaked at $21.9M in Q4 2016.
  • 1,030 funds tracked by Wall St. Rank held CME Group as of Q4 2020.

Based on Swarthmore Group's 13F filing for Q4 2020, filed 8 Feb 2021.